Single agent oral vinorelbine (NVB) in advanced non-small cell lung cancer (NSCLC) in the elderly: Patient benefit improvement by weekly schedule

7120 Background:Single agent IV NVB has proven its effectiveness in elderly NSCLC pts with reduced toxicity. IV and oral NVB formulation have proven comparable bioavailability. This phase II was co...